Go Pro

MetLife (MET) Stock Forecast & Price Target

MetLife logo
$97.51 -1.72 (-1.73%)
As of 03:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

MetLife - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
1
Buy
12

Based on 13 Wall Street analysts who have issued ratings for MetLife in the last 12 months, the stock has a consensus rating of "Buy." Out of the 13 analysts, 1 has given a hold rating, 11 have given a buy rating, and 1 has given a strong buy rating for MET.

Consensus Price Target

$102.21
4.82% Upside
According to the 13 analysts' twelve-month price targets for MetLife, the average price target is $102.21. The highest price target for MET is $111.00, while the lowest price target for MET is $90.00. The average price target represents a forecasted upside of 4.82% from the current price of $97.51.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MET and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for MetLife and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MET Analyst Ratings Over Time

TypeCurrent Forecast
9/4/25 to 9/4/26
1 Month Ago
8/5/25 to 8/5/26
3 Months Ago
6/6/25 to 6/6/26
1 Year Ago
9/4/24 to 9/4/25
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
11 Buy rating(s)
11 Buy rating(s)
9 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$102.21$100.50$95.31$95.60
Forecasted Upside4.82% Upside4.20% Upside12.65% Upside16.96% Upside
Consensus RatingBuyModerate BuyModerate BuyModerate Buy

MET Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MET Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

MetLife Stock vs. The Competition

TypeMetLifeFinance CompaniesBroader Market
Consensus Rating Score
3.00
2.28
2.53
Consensus RatingBuyHoldModerate Buy
Predicted Upside4.41% Upside26.99% Upside13.93% Upside
News Sentiment Rating
Positive News

See Recent MET News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/24/2026
Evercore Inc logo
Evercore
3 of 5 stars
 Reiterated RatingMixed
8/24/2026
Morgan Stanley logo
Morgan Stanley
3 of 5 stars
Nigel Dally
2 of 5 stars
Boost TargetOverweight$103.00 ➝ $111.00+16.15%
8/19/2026Boost TargetOverweight$101.00 ➝ $109.00+12.56%
8/11/2026Boost TargetOverweight$106.00 ➝ $108.00+11.40%
8/11/2026Boost TargetOutperform$105.00 ➝ $108.00+11.39%
8/6/2026Boost TargetOverweight$94.00 ➝ $97.00+0.57%
7/22/2026Boost TargetBuy$87.00 ➝ $105.00+11.84%
7/15/2026 Set Target$103.00+11.65%
7/10/2026Boost TargetBuy$97.00 ➝ $103.00+13.02%
7/9/2026Boost TargetOutperform$95.00 ➝ $102.00+13.22%
7/8/2026Boost TargetBuy$102.00 ➝ $105.00+15.60%
6/24/2026Boost TargetNeutral$86.00 ➝ $90.00+2.02%
6/15/2026 UpgradeBuy (B-)Buy (B)
4/14/2026Lower TargetBuy$103.00 ➝ $99.00+29.81%
9/16/2025UpgradeStrong-Buy
1/23/2025Initiated CoverageMarket Perform$97.00+13.09%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 04:10 PM ET.


Should I Buy MetLife Stock? MET Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 3, 2026. Please send any questions or comments about these MetLife pros and cons to contact@marketbeat.com.

MetLife
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in MetLife, Inc.:

  • MetLife, Inc. recently reported second-quarter earnings of $2.43 per share, which exceeded the consensus estimate of $2.30 by $0.13, demonstrating strong profitability with a return on equity of 23.39% and a net margin of 4.57%.
  • The company announced a $3.00 billion share buyback plan on August 5th, allowing it to repurchase up to 4.8% of its stock, a move that typically signals management confidence that the shares are undervalued and supports shareholder value.
  • MetLife, Inc. declared a quarterly dividend of $0.5925 per share, which will be paid on September 8th, offering an attractive annualized dividend yield of 2.5% with a sustainable payout ratio of 45.40%.
  • Analyst sentiment has improved significantly, with the consensus rating upgraded to "Buy" and the average price target raised to $102.21, reflecting recent positive actions such as Wall Street Zen raising its rating to "buy" and Keefe, Bruyette & Woods increasing its price objective to $108.00.
  • With the current stock price at $99.15, the shares are trading near their 52-week high of $100.93, indicating strong momentum and a significant recovery from the 52-week low of $67.33, which suggests positive market reception of the company's recent performance.

MetLife
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in MetLife, Inc. for these reasons:

  • MetLife, Inc. reported revenue of $13.52 billion for the quarter, which fell significantly short of the analyst consensus estimate of $19.67 billion, raising concerns about the company's top-line growth trajectory despite the EPS beat.
  • The company's liquidity position appears weak, with a current ratio of 0.20 and a quick ratio of 0.20, indicating that it has limited short-term assets to cover its immediate liabilities, which could pose financial stress in a volatile market.
  • Short interest in MetLife, Inc. has increased to 11,308,929 shares as of the August 14, 2026 record date, representing a month-to-month change of 0.17% and a short percentage of float of 1.76%, suggesting that a portion of the market remains skeptical about the stock's future performance.
  • Despite the recent earnings beat, the company's GAAP EPS was only $1.09, which is significantly lower than the non-GAAP EPS of $2.43, highlighting a substantial gap between accounting standards and reported performance that may concern value-focused investors.
  • MetLife, Inc. operates in the insurance sector, which is subject to regulatory and market risks, and the company's debt-to-equity ratio of 0.52, while manageable, still represents a level of leverage that could impact financial flexibility during economic downturns.

MET Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for MetLife is $102.21, with a high forecast of $111.00 and a low forecast of $90.00.

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MetLife in the last year. There is currently 1 hold rating, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MET shares.

According to analysts, MetLife's stock has a predicted upside of 4.82% based on their 12-month stock forecasts.

Over the previous 90 days, MetLife's stock had 1 upgrade by analysts.

Analysts like MetLife more than other "finance" companies. The consensus rating for MetLife is Buy while the average consensus rating for "finance" companies is Hold. Learn more on how MET compares to other companies.


MarketBeat monitors more than a dozen sources for MetLife analyst ratings, with the most recent rating issued on 8/24/2026.
From Our Partners